Logo image of PXLW

PIXELWORKS INC (PXLW) Stock Fundamental Analysis

USA - NASDAQ:PXLW - US72581M4042 - Common Stock

14.24 USD
+2.26 (+18.86%)
Last: 10/2/2025, 5:05:32 PM
14.62 USD
+0.38 (+2.67%)
After Hours: 10/2/2025, 5:05:32 PM
Fundamental Rating

2

Overall PXLW gets a fundamental rating of 2 out of 10. We evaluated PXLW against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. PXLW may be in some trouble as it scores bad on both profitability and health. PXLW has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

PXLW had negative earnings in the past year.
In the past year PXLW has reported a negative cash flow from operations.
PXLW had negative earnings in each of the past 5 years.
PXLW had a negative operating cash flow in each of the past 5 years.
PXLW Yearly Net Income VS EBIT VS OCF VS FCFPXLW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

PXLW has a worse Return On Assets (-53.99%) than 88.39% of its industry peers.
Industry RankSector Rank
ROA -53.99%
ROE N/A
ROIC N/A
ROA(3y)-29.25%
ROA(5y)-28.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PXLW Yearly ROA, ROE, ROICPXLW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

PXLW has a better Gross Margin (50.51%) than 64.29% of its industry peers.
In the last couple of years the Gross Margin of PXLW has remained more or less at the same level.
PXLW does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.89%
GM growth 5Y0.58%
PXLW Yearly Profit, Operating, Gross MarginsPXLW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

3

2. Health

2.1 Basic Checks

PXLW does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PXLW has been increased compared to 1 year ago.
Compared to 5 years ago, PXLW has more shares outstanding
There is no outstanding debt for PXLW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PXLW Yearly Shares OutstandingPXLW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
PXLW Yearly Total Debt VS Total AssetsPXLW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -14.37, we must say that PXLW is in the distress zone and has some risk of bankruptcy.
PXLW has a worse Altman-Z score (-14.37) than 82.14% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -14.37
ROIC/WACCN/A
WACC11.37%
PXLW Yearly LT Debt VS Equity VS FCFPXLW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

PXLW has a Current Ratio of 2.80. This indicates that PXLW is financially healthy and has no problem in meeting its short term obligations.
PXLW has a Current ratio of 2.80. This is comparable to the rest of the industry: PXLW outperforms 50.89% of its industry peers.
PXLW has a Quick Ratio of 2.35. This indicates that PXLW is financially healthy and has no problem in meeting its short term obligations.
PXLW has a Quick ratio (2.35) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.8
Quick Ratio 2.35
PXLW Yearly Current Assets VS Current LiabilitesPXLW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

3

3. Growth

3.1 Past

PXLW shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.52%.
PXLW shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -44.05%.
PXLW shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.88% yearly.
EPS 1Y (TTM)-9.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.9%
Revenue 1Y (TTM)-44.05%
Revenue growth 3Y-7.79%
Revenue growth 5Y-8.88%
Sales Q2Q%-3.34%

3.2 Future

PXLW is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.88% yearly.
PXLW is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.06% yearly.
EPS Next Y21.32%
EPS Next 2Y23.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-18.5%
Revenue Next 2Y1.06%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PXLW Yearly Revenue VS EstimatesPXLW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
PXLW Yearly EPS VS EstimatesPXLW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

1

4. Valuation

4.1 Price/Earnings Ratio

PXLW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PXLW. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PXLW Price Earnings VS Forward Price EarningsPXLW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PXLW Per share dataPXLW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

A more expensive valuation may be justified as PXLW's earnings are expected to grow with 23.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.88%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PXLW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PIXELWORKS INC

NASDAQ:PXLW (10/2/2025, 5:05:32 PM)

After market: 14.62 +0.38 (+2.67%)

14.24

+2.26 (+18.86%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners15.6%
Inst Owner Change-92.87%
Ins Owners5.43%
Ins Owner Change13.88%
Market Cap76.04M
Analysts82.22
Price Target11.9 (-16.43%)
Short Float %3.21%
Short Ratio1.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.65%
Min EPS beat(2)4.84%
Max EPS beat(2)12.46%
EPS beat(4)4
Avg EPS beat(4)12.4%
Min EPS beat(4)4.84%
Max EPS beat(4)23.75%
EPS beat(8)7
Avg EPS beat(8)7.02%
EPS beat(12)11
Avg EPS beat(12)10.04%
EPS beat(16)15
Avg EPS beat(16)14.28%
Revenue beat(2)0
Avg Revenue beat(2)-5.64%
Min Revenue beat(2)-6.44%
Max Revenue beat(2)-4.84%
Revenue beat(4)0
Avg Revenue beat(4)-4.79%
Min Revenue beat(4)-6.44%
Max Revenue beat(4)-1.68%
Revenue beat(8)0
Avg Revenue beat(8)-3.21%
Revenue beat(12)1
Avg Revenue beat(12)-2.7%
Revenue beat(16)3
Avg Revenue beat(16)-2.15%
PT rev (1m)0%
PT rev (3m)-27.08%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-36.67%
EPS NY rev (1m)-1.5%
EPS NY rev (3m)-11.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-30.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-20.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.24
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.6
EYN/A
EPS(NY)-2.18
Fwd EYN/A
FCF(TTM)-4.83
FCFYN/A
OCF(TTM)-4.62
OCFYN/A
SpS6.36
BVpS-4.2
TBVpS-7.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -53.99%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.51%
FCFM N/A
ROA(3y)-29.25%
ROA(5y)-28.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.89%
GM growth 5Y0.58%
F-Score3
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 37.54%
Cap/Sales 3.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.8
Quick Ratio 2.35
Altman-Z -14.37
F-Score3
WACC11.37%
ROIC/WACCN/A
Cap/Depr(3y)85.29%
Cap/Depr(5y)76.4%
Cap/Sales(3y)6.56%
Cap/Sales(5y)6.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.9%
EPS Next Y21.32%
EPS Next 2Y23.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.05%
Revenue growth 3Y-7.79%
Revenue growth 5Y-8.88%
Sales Q2Q%-3.34%
Revenue Next Year-18.5%
Revenue Next 2Y1.06%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.93%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.37%
OCF growth 3YN/A
OCF growth 5YN/A